This paper summarises key information on New Psychoactive Substances (NPS)and evidence gaps. The paper is structured around main themes - demand/ prevalence of use, supply, impact/ harms, responses (enforcement, prevention, and treatment); and evidence gaps. In each section, information on what we know about NPS in Scotland is set in the context of information from the rest of the UK and internationally.
An estimated 107,800 (95% credible interval 101,600-115,800) people were living with HIV in the UK in 2013. The overall prevalence was 2.8 per 1,000 population aged 15-59 years (1.9 per 1,000 women and 3.7 per 1,000 men). A quarter (24%, 26,100) of people estimated to be living with HIV were unaware of their infection and remain at risk of passing on their infection if having sex without condoms
These guidelines, produced by the World Health Organisation, aim to reduce the number of deaths from opioid overdose by providing evidence-based recommendations on the availability of naloxone for people likely to witness an opioid overdose along with advice on the resuscitation and post-resuscitation care of opioid overdose in the community.
Each year Public Health England release the Shooting Up report. This details health issues and risk behaviours relating to injecting drug use.
This bulletin presents the latest figures from the Office for National Statistics (ONS) on deaths related to drug poisoning (involving both legal and illegal drugs) and drug misuse (involving illegal drugs) in England and Wales for the last five years (2009 to 2013).
Injecting drug use continues to be the most important risk factor for HCV infection in the UK. Data from the Unlinked Anonymous Monitoring (UAM) survey of people who inject drugs (PWID) suggest that levels of infection in this group remain high in 2013 (50% in England, 32% in Northern Ireland and 47% in Wales); in 2013 to 2014, 57% of PWID surveyed in Scotland tested positive for antibodies to hepatitis C.